JP2025513501A5 - - Google Patents

Info

Publication number
JP2025513501A5
JP2025513501A5 JP2024562210A JP2024562210A JP2025513501A5 JP 2025513501 A5 JP2025513501 A5 JP 2025513501A5 JP 2024562210 A JP2024562210 A JP 2024562210A JP 2024562210 A JP2024562210 A JP 2024562210A JP 2025513501 A5 JP2025513501 A5 JP 2025513501A5
Authority
JP
Japan
Prior art keywords
composition according
pharmaceutically acceptable
acceptable salt
solid composition
aqueous composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2024562210A
Other languages
English (en)
Japanese (ja)
Other versions
JP2025513501A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2023/060686 external-priority patent/WO2023203255A1/en
Publication of JP2025513501A publication Critical patent/JP2025513501A/ja
Publication of JP2025513501A5 publication Critical patent/JP2025513501A5/ja
Pending legal-status Critical Current

Links

JP2024562210A 2022-04-22 2023-04-24 凍結乾燥組成物 Pending JP2025513501A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US202263333557P 2022-04-22 2022-04-22
US63/333,557 2022-04-22
EP22173920.4 2022-05-17
EP22173920 2022-05-17
PCT/EP2023/060686 WO2023203255A1 (en) 2022-04-22 2023-04-24 Freeze dried compositions

Publications (2)

Publication Number Publication Date
JP2025513501A JP2025513501A (ja) 2025-04-24
JP2025513501A5 true JP2025513501A5 (cg-RX-API-DMAC7.html) 2026-05-08

Family

ID=86330122

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2024562210A Pending JP2025513501A (ja) 2022-04-22 2023-04-24 凍結乾燥組成物

Country Status (7)

Country Link
US (1) US20250275967A1 (cg-RX-API-DMAC7.html)
EP (1) EP4511007A1 (cg-RX-API-DMAC7.html)
JP (1) JP2025513501A (cg-RX-API-DMAC7.html)
CN (1) CN119403545A (cg-RX-API-DMAC7.html)
CA (1) CA3249784A1 (cg-RX-API-DMAC7.html)
TW (2) TW202406551A (cg-RX-API-DMAC7.html)
WO (2) WO2023203257A1 (cg-RX-API-DMAC7.html)

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JO3429B1 (ar) 2001-08-13 2019-10-20 Janssen Pharmaceutica Nv مشتقات برميدينات مثبطة فيروس الايدز
EP2330213A1 (en) 2003-03-05 2011-06-08 Halozyme, Inc. Soluble hyaluronidase glycoprotein (sHASEGP), process for preparing the same, uses and pharmaceutical compositions comprising thereof
PT3366278T (pt) 2006-06-23 2024-10-21 Janssen Sciences Ireland Unlimited Co Suspensões aquosas de tmc278
BRPI0715113A2 (pt) * 2006-07-26 2013-06-04 Sandoz Ag Sandoz Sa Sandoz Ltd formulaÇço de caspofungina
AR065720A1 (es) * 2007-03-14 2009-06-24 Tibotec Pharm Ltd Polvos para reconstitucion que comprenden rilpivirina dispersos en ciertos polimeros. uso. proceso.
GB2513060B (en) * 2010-06-08 2015-01-07 Rb Pharmaceuticals Ltd Microparticle buprenorphine suspension
HRP20201241T1 (hr) * 2011-04-15 2020-11-27 Janssen Pharmaceutica N.V. Nanosuspenzije lijeka osušene zamrzavanjem
WO2018013673A1 (en) * 2016-07-13 2018-01-18 Reform Biologics, Llc Stabilizing excipients for therapeutic protein formulations
WO2022109555A1 (en) 2020-11-17 2022-05-27 Janssen Sciences Ireland Unlimited Company Treatment or prevention of hiv infection

Similar Documents

Publication Publication Date Title
Chaturvedi et al. A review on mucoadhesive polymer used in nasal drug delivery system
JP2023537609A5 (cg-RX-API-DMAC7.html)
JP2013511557A5 (cg-RX-API-DMAC7.html)
AU2008225501B2 (en) Lyophilized preparation comprising influenza vaccine, and method for preparation thereof
JP4902103B2 (ja) 凍結乾燥フォームによる生物活性材料の保存
WO1991000739A1 (en) Stable motilin preparation
JP2007504129A5 (cg-RX-API-DMAC7.html)
IL255113B (en) Preparations for administration through the skin that include complexes of an active substance with calcium phosphate and methods of using them
JPH11506100A (ja) ミソプロストールの安定化された分散系
JP2019519570A5 (cg-RX-API-DMAC7.html)
JP2000515543A (ja) ヘルペスウイルスにより起こる感染を予防または治療するためのキトサンと組み合わされたヘパリンまたはヘパラン硫酸の使用
KR20190092481A (ko) 은 및 셀레늄을 포함하는 항생제 조성물
JP6488003B2 (ja) 安定なモンテルカスト溶液
ES2279172T3 (es) Nanoparticulas para la administracion de ingredientes activos, procedimiento para la elaboracion de dichas particulas y composiciones que las contienen.
KR20090057400A (ko) 트롬빈 수용체 길항제의 동결건조된 신속 붕해성 경구 제형
JPS59181224A (ja) 安定なインタ−フエロン製剤の製法
CN101991541A (zh) 阿昔洛韦-壳聚糖纳米粒的制备方法
JP5373616B2 (ja) 鳥インフルエンザウイルス感染の予防的治療のためのポリiclcカプセル化リポソーム
CN101804031A (zh) 一种利巴韦林-壳聚糖季铵盐纳米微粒的制备方法
CN101534821B (zh) 室温稳定的冻干可注射的半合成长春花生物碱类和糖类的药物组合物
JP2025513502A5 (cg-RX-API-DMAC7.html)
CN104721136A (zh) 一种布佐林胺眼用纳米混悬剂及其制备方法
JP2022548221A5 (cg-RX-API-DMAC7.html)
JP2025502242A5 (cg-RX-API-DMAC7.html)
CN104721145A (zh) 一种布佐林胺纳米粒眼用制剂及其制备方法